GS
DVAX

GTS Securities’s Dynavax Technologies DVAX Stock Holding History

GTS Securities’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-101,200
Closed -$1.26M – 4017
2024
Q1 		$1.26M Buy
+101,200
New +$1.32M ﹤0.01% 1820

Other funds holding DVAX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GTS Securities's DVAX Position: Q2 2024 in Review

GTS Securities sold out of Dynavax Technologies (DVAX) in Q2 2024, closing a stake of 40,029 shares — an estimated $497K sold.

GTS Securities first reported a position in DVAX in Q2 2023 and held it in 4 quarters. The position peaked at $497K in Q1 2024. 238 funds tracked by Wall St. Rank hold DVAX as of Q2 2024.

  • GTS Securities reported no remaining Dynavax Technologies position as of Q2 2024 after selling out during the quarter.
  • GTS Securities sold 40,029 Dynavax Technologies shares in Q2 2024, an estimated $497K.
  • GTS Securities first reported a position in Dynavax Technologies in Q2 2023 and held it in 4 quarters.
  • GTS Securities's Dynavax Technologies position peaked at $497K in Q1 2024.
  • 238 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2024.

Based on GTS Securities's 13F filing for Q2 2024, filed 14 Aug 2024.